id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-256224-qprj8vlc	Boixeda, R.	Is chronic obstructive pulmonary disease a protective factor in SARS-CoV-2 infection? The importance of bronchodilator treatment()	2020-09-26		.txt	text/plain	1402	89	50	In a systematic review of infections in patients with COPD that required hospital admission, it was observed that the rhinovirus, respiratory syncytial virus (RSV), and influenza virus were the most prevalent agents, followed by parainfluenza and coronavirus. We have analyzed the prevalence of COPD in patients treated for COVID-19 in our center, specifically evaluating their baseline treatment with inhalers as a potential protective factor against SARS-CoV-2 infection. However, the use of tiotropium was significantly lower in patients with COPD who had been hospitalized for COVID-19 in relation to other cohorts of patients with stable COPD and without SARS-CoV-2 infection and controlled in primary care (12% vs. Members of the COCOHMAT (COhorte COvid del Hospital de MATaró) Group Table 1 Treatment with inhaled corticosteroids and anticholinergics in patients with COPD in series of patients hospitalized due to SARS-CoV-2, severe exacerbation of COPD, and patients in the stable phase (primary care)	./cache/cord-256224-qprj8vlc.txt	./txt/cord-256224-qprj8vlc.txt